MarketCap
Facebook
X
Telegram
MacroGenics Cash Conversion Cycle | MGNX
Annual Cash Conversion Cycle MacroGenics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.6 | -2.19 K | -2.35 K | -713 | -1.24 K | 62.3 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 62.3 | -2.35 K | -1.07 K |
Quarterly Cash Conversion Cycle MacroGenics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 51.2 | 47.3 | 51.4 | - | -2.03 K | - | - | - | -2.32 K | -684 | -2.17 K | - | -13.2 | 364 | -9.63 K | - | 20.3 | -15.5 K | -32.7 K | - | 115 | 104 | 119 | 46.2 | 62 | 110 | 200 | 171 | 130 | 143 | 420 | 8.17 | 749 | 747 | 364 | 49.4 | 77.5 | 3.13 | 63.9 | 13.7 | 7.61 | 16.6 | 2.66 | 48.9 | 14.6 | 29.1 | 15.3 | 12.3 | 9.04 | 7.43 | 8.81 | 19.1 | 5.81 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 749 | -32.7 K | -1.32 K |
Cash Conversion Cycle of other stocks in the Biotechnology industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AnaptysBio
ANAB
|
205 | $ 51.0 | 1.83 % | $ 1.48 B |  USA |
 |
Clovis Oncology
CLVS
|
271 | - | -7.23 % | $ 13 M | USA |
 |
Concert Pharmaceuticals
CNCE
|
5.06 | - | - | $ 401 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
733 | $ 60.26 | 0.06 % | $ 11.6 B | USA |
 |
Genocea Biosciences
GNCA
|
24.9 | - | -15.0 % | $ 3.04 M | USA |
 |
Catalyst Biosciences
CBIO
|
285 | $ 13.99 | 0.84 % | $ 1.25 B | USA |
 |
C4 Therapeutics
CCCC
|
27.9 | $ 2.98 | 0.3 % | $ 247 M | USA |
 |
Codexis
CDXS
|
-15.2 | $ 1.32 | 1.09 % | $ 115 M | USA |
 |
Cerus Corporation
CERS
|
47 | $ 2.62 | 0.38 % | $ 499 M | USA |
 |
G1 Therapeutics
GTHX
|
52.6 | - | - | $ 370 M | USA |
 |
Coherus BioSciences
CHRS
|
149 | $ 1.13 | 0.43 % | $ 132 M | USA |
 |
Celldex Therapeutics
CLDX
|
-3.74 K | $ 31.1 | 1.16 % | $ 2.07 B | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
-90.5 | $ 4.25 | 3.16 % | $ 51.9 M |  Israel |
 |
AbbVie
ABBV
|
284 | $ 264.34 | 0.09 % | $ 468 B | USA |
 |
Humanigen
HGEN
|
598 | - | -81.12 % | $ 4.28 M | USA |
 |
Cocrystal Pharma
COCP
|
51.2 | $ 1.17 | 1.74 % | $ 13.2 M | USA |
 |
AbCellera Biologics
ABCL
|
173 | $ 12.7 | 0.4 % | $ 3.79 B |  Canada |
 |
Abeona Therapeutics
ABEO
|
-695 | $ 5.4 | 2.65 % | $ 286 M | USA |
 |
Collegium Pharmaceutical
COLL
|
537 | $ 22.53 | 0.2 % | $ 713 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
-402 | $ 116.1 | 4.93 % | $ 12.1 B | USA |
 |
Фармсинтез
LIFE
|
-15.9 | - | - | - |  Russia |
 |
Cardiff Oncology
CRDF
|
294 | $ 1.24 | 0.74 % | $ 82.9 M | USA |
 |
Karuna Therapeutics
KRTX
|
15.9 | - | - | $ 12.2 B | USA |
 |
Curis
CRIS
|
64.7 | $ 0.83 | 1.1 % | $ 10.9 M | USA |
 |
CorMedix
CRMD
|
359 | $ 7.85 | 1.03 % | $ 565 K | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
-4.27 K | $ 84.95 | 0.13 % | $ 7.99 B | USA |
 |
CRISPR Therapeutics AG
CRSP
|
1.3 K | $ 54.23 | 0.23 % | $ 4.88 B |  Schweiz |
 |
Champions Oncology
CSBR
|
9.02 | $ 4.9 | 0.1 % | $ 67.8 M | USA |
 |
Chimerix
CMRX
|
52.5 | - | - | $ 756 M | USA |
 |
Cue Biopharma
CUE
|
43.1 | $ 31.41 | 1.45 % | $ 2.98 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
50 | $ 4.85 | 0.2 % | $ 929 M | Canada |
 |
Cytokinetics, Incorporated
CYTK
|
71.3 | $ 64.66 | 0.17 % | $ 7.77 M | USA |
 |
Daré Bioscience
DARE
|
-1.64 K | $ 0.78 | 4.73 % | $ 8.72 M | USA |
 |
Adagene
ADAG
|
58.9 | $ 2.93 | 2.86 % | $ 173 M |  China |